NANCY MORTENSEN: Open Payments
NPI 1841249380 · PROVO, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,862 in 92 payments from 21 companies in 2025. Trend: 2023 $618 · 2024 $1,088 · 2025 $2,862
Food & beverage: $1,599Long term medical supply or device loan: $1,164Education: $100
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 14 | $1,203 |
| PFIZER INC. | 15 | $237 |
| Daiichi Sankyo Inc. | 15 | $226 |
| AstraZeneca Pharmaceuticals LP | 9 | $222 |
| Merck Sharp & Dohme LLC | 6 | $147 |
| Janssen Biotech, Inc. | 5 | $119 |
| GlaxoSmithKline, LLC. | 2 | $108 |
| SEAGEN INC. | 1 | $100 |
| ARRAY BIOPHARMA INC | 8 | $96 |
| PUMA BIOTECHNOLOGY, INC. | 3 | $68 |
Products named: KISQALI, IMFINZI, ENHERTU, KEYTRUDA, DATROWAY, IBRANCE, ZEJULA, TALVEY.
Industry payments across UT — which companies pay providers there.
